Towards Healthcare
Humanized Mouse and Rat Model Market to Reach USD 563.03 Mn by 2034

Humanized Mouse and Rat Model Market Poised for Strong Growth with Expanding Role in Immuno-Oncology and AI Integration

Market insights predict, the humanized mouse and rat model industry is expected to grow from USD 257.2 million in 2024 to USD 563.03 million by 2034, driven by a CAGR of 8.15%. The humanized mouse and rat model market is increasing due to growing demand for precision medicines. North America led the market due to the presence of established market players.

  • Insight Code: 6002
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The humanized mouse and rat model market holds a valuation of USD 278.1 million as of 2025, and will expand to USD 563.03 million by 2034, achieving a CAGR of 8.15% between 2024 and 2034.

North America is currently leading the humanized mouse and rat model market due to its advanced biomedical research infrastructure, strong public and private funding, and high adoption of humanized models in pharmaceutical and biotechnology R&D.

The humanized mouse and rat model market includes segments such as by model type, by application, by species, by end user, and by region.

Some key players include Taconic Biosciences, The Jackson Laboratory, Charles River Laboratories, Harbour BioMed, Crown Bioscience, Biocytogen Pharmaceuticals, and Champions Oncology.

Supportive regulatory reforms, increasing clinical research activities, and collaborations between academia and biopharma firms are fueling market expansion, especially in cost-effective preclinical solutions.

Ministry of Health and Family Welfare, Government of India National Institutes of Health FDA WHO Press Information Bureau CDC.